Skip to main content
. 2020 Jul 28;63(17):9300–9315. doi: 10.1021/acs.jmedchem.0c00451

Figure 2.

Figure 2

(A) Aurora kinase inhibitor GSK1070916, (B) 1-p-chlorobenzyl-7-azaindole-3-α-piperidylmethanol has in vivo activity against P. berghei, (C) PfHsp90 inhibitor IND31119, and (D) drug candidates incorporating a core 7-azaindole scaffold, vemurafenib, PLX3397, and AZD5363.